• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平与选定环糊精的相互作用及随后的溶解度-渗透性权衡。

The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.

机构信息

Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

出版信息

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1293-9. doi: 10.1016/j.ejpb.2013.05.018. Epub 2013 Jun 11.

DOI:10.1016/j.ejpb.2013.05.018
PMID:23770429
Abstract

The purpose of this study was to investigate the interaction of 2-hydroxypropyl-β-cyclodextrin (HPβCD) and 2,6-dimethyl-β-cyclodextrin (DMβCD) with the lipophilic drug nifedipine and to investigate the subsequent solubility-permeability interplay. Solubility curves of nifedipine with HPβCD and DMβCD in MES buffer were evaluated using phase solubility methods. Then, the apparent permeability of nifedipine was investigated as a function of increasing HPβCD/DMβCD concentration in the hexadecane-based PAMPA model. The interaction with nifedipine was CD dependent; significantly higher stability constant was obtained for DMβCD in comparison with HPβCD. Moreover, nifedipine displays different type of interaction with these CDs; a 1:1 stoichiometric inclusion complex was apparent with HPβCD, while 1:2 stoichiometry was apparent for DMβCD. In all cases, decreased apparent intestinal permeability of nifedipine as a function of increasing CD level and nifedipine apparent solubility was obtained. A quasi-equilibrium mass transport analysis was developed to explain this solubility-permeability interplay; the model enabled excellent quantitative prediction of nifedipine's permeability as a function of CD concentrations. This work demonstrates that when using CDs in solubility-enabling formulations, a trade-off exists between solubility increase and permeability decrease that must not be overlooked. This trade-off was found to be independent of the type of CD-drug interaction. The transport model presented here can aid in striking the appropriate solubility-permeability balance in order to achieve optimal overall absorption.

摘要

本研究旨在考察亲脂性药物硝苯地平与 2-羟丙基-β-环糊精(HPβCD)和 2,6-二甲基-β-环糊精(DMβCD)的相互作用,并研究随后的溶解度-渗透性相互作用。采用相溶解度法评价硝苯地平与 HPβCD 和 DMβCD 在 MES 缓冲液中的溶解度曲线。然后,在基于十六烷的 PAMPA 模型中,考察硝苯地平的表观渗透随 HPβCD/DMβCD 浓度增加的变化情况。与硝苯地平的相互作用与 CD 有关;与 HPβCD 相比,DMβCD 获得了更高的稳定常数。此外,硝苯地平与这些 CD 显示出不同类型的相互作用;与 HPβCD 明显形成 1:1 化学计量的包合络合物,而与 DMβCD 则形成 1:2 化学计量的络合物。在所有情况下,随着 CD 水平的增加和硝苯地平表观溶解度的增加,硝苯地平的表观肠道渗透性均降低。建立了准平衡质量传递分析来解释这种溶解度-渗透性相互作用;该模型能够极好地定量预测硝苯地平的渗透性随 CD 浓度的变化。本工作表明,在使用 CD 增加溶解度的配方中,溶解度的增加与渗透性的降低之间存在权衡,不可忽视。这种权衡与 CD-药物相互作用的类型无关。本文提出的传输模型有助于在溶解度和渗透性之间取得适当的平衡,以实现最佳的整体吸收。

相似文献

1
The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.硝苯地平与选定环糊精的相互作用及随后的溶解度-渗透性权衡。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1293-9. doi: 10.1016/j.ejpb.2013.05.018. Epub 2013 Jun 11.
2
Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.迈向基于环糊精的成功的亲脂性药物口服给药增溶制剂:溶解度-渗透性权衡、生物相关溶出度及未搅动水层
Mol Pharm. 2017 Jun 5;14(6):2138-2146. doi: 10.1021/acs.molpharmaceut.7b00275. Epub 2017 May 24.
3
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay.Captisol(SBE7-β-环糊精)在口服增溶制剂中的应用:与羟丙基-β-环糊精的比较及溶解度-渗透性相互作用
Eur J Pharm Sci. 2015 Sep 18;77:73-8. doi: 10.1016/j.ejps.2015.05.024. Epub 2015 May 22.
4
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone.使用环糊精作为药物增溶剂时的溶解度-渗透性相互作用:机制建模及其在孕酮中的应用。
J Pharm Sci. 2010 Jun;99(6):2739-49. doi: 10.1002/jps.22033.
5
Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations.环糊精制剂增加亲脂性药物溶解度和降低渗透性的权衡。
PLoS One. 2013 Jul 16;8(7):e68237. doi: 10.1371/journal.pone.0068237. Print 2013.
6
A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.脂溶性药物口服传递的双赢解决方案:通过无定形固体分散体实现过饱和,在不牺牲肠黏膜通透性的情况下增加表观溶解度。
Mol Pharm. 2012 Jul 2;9(7):2009-16. doi: 10.1021/mp300104s. Epub 2012 Jun 20.
7
Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation.预测环糊精在增溶配方中溶解度-渗透性相互作用:模型验证。
Int J Pharm. 2012 Jul 1;430(1-2):388-91. doi: 10.1016/j.ijpharm.2012.03.017. Epub 2012 Mar 23.
8
The Solubility-Permeability Trade-Off of Progesterone With Cyclodextrins Under Physiological Conditions: Experimental Observations and Computer Simulations.在生理条件下,与环糊精的孕激素溶解度-渗透性权衡:实验观察和计算机模拟。
J Pharm Sci. 2018 Jan;107(1):488-494. doi: 10.1016/j.xphs.2017.09.032. Epub 2017 Oct 12.
9
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.使用共溶剂增溶时的溶解度-渗透性相互作用:改变我们使用增溶配方的方式。
Mol Pharm. 2012 Mar 5;9(3):581-90. doi: 10.1021/mp200460u. Epub 2012 Feb 22.
10
Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay.依托泊苷不同增溶制剂的直接比较及其溶解度-渗透性的相互作用
J Pharm Sci. 2015 Sep;104(9):2941-7. doi: 10.1002/jps.24496. Epub 2015 May 18.

引用本文的文献

1
Development of Nifedipine Phytantriol-Based Cubosomes and In Vitro Simulation of Administration Through Pediatric Feeding Tubes.基于硝苯地平-植烷三醇的立方液晶纳米粒的研制及经儿科喂食管给药的体外模拟
Pharmaceutics. 2025 Jun 25;17(7):828. doi: 10.3390/pharmaceutics17070828.
2
Physiologically Based Pharmacokinetic Modeling for Predicting Drug Levels After Bariatric Surgery: Vardenafil Exposure Before vs. After Gastric Sleeve/Bypass.基于生理的药代动力学模型预测减肥手术后的药物水平:胃袖状切除术/胃旁路术后伐地那非的暴露情况对比
Biomolecules. 2025 Jul 7;15(7):975. doi: 10.3390/biom15070975.
3
Erectile Dysfunction Therapy of Bariatric Patients: Tadalafil Biopharmaceutics and Pharmacokinetics Before vs. After Gastric Sleeve/Bypass.
肥胖患者勃起功能障碍治疗:胃袖状切除术/旁路术前与术后他达拉非的生物药剂学和药代动力学对比。
AAPS J. 2024 Nov 14;26(6):114. doi: 10.1208/s12248-024-00985-9.
4
Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins.用环糊精控制利鲁唑的溶解度、释放速率和渗透性。
Pharmaceutics. 2024 Jun 3;16(6):757. doi: 10.3390/pharmaceutics16060757.
5
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib.β-环糊精和羟丙基-β-环糊精作为酪氨酸激酶抑制剂阿来替尼包合物的溶解度、溶出速率及口服生物利用度评估
Pharmaceuticals (Basel). 2024 Jun 5;17(6):737. doi: 10.3390/ph17060737.
6
The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass.肥胖症患者药物治疗的复杂性:胃袖状切除术/胃旁路术后与术前西地那非的生物药剂学和药代动力学
Pharmaceutics. 2023 Dec 18;15(12):2795. doi: 10.3390/pharmaceutics15122795.
7
Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets.硝苯地平-羟丙基-β-环糊精和硝苯地平-甲基-β-环糊精的形成及理化性质评价:口腔崩解片的研制
Pharmaceuticals (Basel). 2022 Aug 12;15(8):993. doi: 10.3390/ph15080993.
8
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin.胃旁路术后药物吸收的优化计算机模拟:以二甲双胍为例。
Pharmaceutics. 2021 Nov 5;13(11):1873. doi: 10.3390/pharmaceutics13111873.
9
Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions.非漏槽条件下难溶性药物的剂量依赖性溶解度-渗透性相互作用
Pharmaceutics. 2021 Mar 2;13(3):323. doi: 10.3390/pharmaceutics13030323.
10
Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies.药用植物植物化学物的抗病毒作用:应用和药物传递策略。
Drug Deliv Transl Res. 2020 Apr;10(2):354-367. doi: 10.1007/s13346-019-00691-6.